您的位置：首页 > 产品中心 > 552-94-3， Salsalate
Salsalate
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 3216615 | 50 MG | 1660 | |||
| 3216615 | 250 MG | 5770 |
产品别名
552-94-3
Salsalate
2-Hydroxybenzoic acid 2-carboxyphenyl ester
salicyloxysalicylic acid
disalicylic acid
2-(2-Hydroxybenzoyl)oxybenzoic acid
Salicylsalicylic acid
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C14H10O5 |
| Molecular weight | 258.23 |
| EC number【EC 号】 | 209-027-4 |
| MDL number | MFCD00020252 |
| PubChem Substance ID【PubChem化学物质编号】 | 329825134 |
| NACRES | NA.77 |
| Application【应用】 | Salsalate was used to study the effect on palmitate-induced insulin resistance and hepatic steatosis in obese rats. |
| Biochem/physiol Actions【生化/生理作用】 | Salsalate is a nonsteroidal anti-inflammatory drug (NSAID), a nonacetylated salicylate with no more problems of gastrointestinal bleeding than placebo. It inhibits synthesis and release of prostaglandins through the inactivation of cyclooxygenase-1 (COX-1) and COX-2. Salsalate is currently being investigated as a treatment for Type 2 diabetes with possible use to prevent the disease in people at risk. It reduces blood glucose concentrations in patients with type 2 diabetes, as well as in insulin-resistant patients without diabetes. |
产品性质
| Assay【测定】 | ≥98% (HPLC) |
| form【形式】 | powder |
| color【颜色】 | white to tan |
| solubility【溶解性】 | DMSO: ≥15 mg/mL |
| storage temp.【储存温度】 | room temp |
| SMILES string | OC(=O)c1ccccc1OC(=O)c2ccccc2O |
| InChI | 1S/C14H10O5/c15-11-7-3-1-5-9(11)14(18)19-12-8-4-2-6-10(12)13(16)17/h1-8,15H,(H,16,17) |
| InChI key | WVYADZUPLLSGPU-UHFFFAOYSA-N |
| packaging【包装】 | 50, 250 mg in glass bottle |
安全信息
| Pictograms【象形图】 | GHS07,GHS09 |
| Signal word【警示用语：】 | Warning |
| Hazard Statements | H302 - H400 |
| Precautionary Statements | P273 - P301 + P312 + P330 |
| Hazard Classifications【危险分类】 | Acute Tox. 4 Oral - Aquatic Acute 1 |
| Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
| WGK | WGK 3 |
